Our Team & Advisors

Our team includes medical specialists in mood and substance use disorders, as well as leading researchers and practitioners in psychedelic therapies.
Dr. Radowitz’s focus is preventive medicine, getting to the underlying source before it manifests as “dis-ease,” a misalignment of mind, body, and spirit, evolving his career as a board-certified Internist to psychedelics for mental health.

Dr. Julia Mirer is a psychedelic medicine advisor and advocate, bridging eastern and western practices, merging them to create a new paradigm for integrative health and wellness.

Eva Muschkin is a Nurse Practitioner who believes in a holistic approach to patient care, encompassing physical, emotional, social, and spiritual wellbeing. She worked in primary care prior but became more interested in how psychedelic medicine can benefit mental health.

Steven Radowitz, MD

Chief Medical Officer

Dr. Radowitz has a wealth of experience seeing the effects trauma can have on our physical health firsthand. He joined Nushama to oversee and develop treatment modalities, believing psychedelics are the future of mental wellness as current solutions treat symptoms, not underlying issues.

Dr. Radowitz also runs the primary care program at Goldman Sachs and has practiced internal medicine and primary care since 1998. Originally from Montreal, he completed his M.D. at Chicago Medical School. He worked at St. Vincent’s in general medicine and HIV/AIDS units and was Medical Director of the inpatient alcohol and opiate detox and treatment unit.

Dr. Radowitz’s focus is preventive medicine, getting to the underlying source before it manifests as “dis-ease,” a misalignment of mind, body, and spirit. He believes psychedelics are a powerful tool to discover the origin of imbalance. On a spiritual journey with Kabbalah, he also studies meditation and yoga. At Nushama, he leads one of the most experienced teams in psychedelic medicine.

Julia Mirer, MD

Director of Strategy & Impact

Dr. Julia Mirer is an advisor and advocate in the emerging field of psychedelic medicine, serving as a bridge between eastern and western practices, committed to merging them to help create a new paradigm for integrative health and wellness.

Her passion lies in education and advocacy for the responsible use of these medicines. Dr. Mirer believes that a successful future for this field depends on the interplay between policy, research, and clinics and has therefore positioned herself to play a role in each.

Nationally, Dr. Mirer is an advisor for the Plant Medicine Coalition, lobbying the NIH for $100 million for psychedelic research. In Florida, she works in psychedelic clinical research at Segal Trials as a facilitator for USONA’s phase 2 trial using Psilocybin for Major Depression. Most recently, Dr. Mirer joined Nushama as Director of Strategy, where she hopes to combine all of her experience to realize the vision of a new type of healthcare system.

Eva Muschkin, MSN, AGACNP-BC

Nurse Practioner

Eva Muschkin is a Nurse Practitioner at Nushama. She is passionate about using the power of psychedelics to help people with various mental health conditions. Eva believes in a holistic approach to patient care, encompassing physical, emotional, social, and spiritual wellbeing. She worked in primary care for over two years but became more interested in learning about depression and anxiety to understand better treatment approaches.

Eva studied psychology at Ohio State University, lived abroad in Madrid, Spain, and then graduated from Vanderbilt University with her Master’s Degree in Nursing. After becoming a Nurse Practitioner, she moved to New York City for work. In her free time, she enjoys tennis, skiing, and being on the beach.